HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
114163.0,216412,2199-08-16 07:05:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 PICC LINE - START [**2199-8-15**] 06:50 PM
   Placed in IR [**2199-8-14**]
 DIALYSIS CATHETER - START [**2199-8-15**] 06:50 PM
   [**2199-8-15**]:
   - urine successfully alkalinized with pH > 7.5.  Stopped bicarb drip.
   - continued cvvh
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-16**] 06:50 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.2
C (97.2
   HR: 74 (69 - 113) bpm
   BP: 147/79(96) {107/66(76) - 168/107(121)} mmHg
   RR: 16 (8 - 25) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 53 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                    755 mL
                                                                    701 mL
   PO:
             60 mL
   TF:
   IVF:
                                                                    755 mL
                                                                    641 mL
   Blood products:
   Total out:
                                                                    672 mL
                                                                  1,008 mL
   Urine:
                                                                    400 mL
                                                                  1,000 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                     83 mL
                                                                   -307 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   VBG: 7.48/43/35/28/
   Physical Examination
   GEN: Sitting in bed, poor eye-contact, NAD
   [**Name2 (NI) 1824**]: PERRL, [**Name (NI) **] but with several beats of nystagmus with gaze in
   both directions, O/P clear
   Neck: supple, no LAD, no JVD
   CV: RRR no m/g/r
   PULM: CTAB no w/r/r
   ABD: S/NT/ND normoactive bowel sounds
   EXT: no c/c/e, fistula in LUE, no palpable thrill
   Neuro: AAOx3, CN II-XII intact, normal sensory and motor exam
   SKIN: mild alopecia
   Labs / Radiology
   522
   8
   88 mg/dL
   0.8 mg/dL
   28 mEq/L
   3.5 mEq/L
   5 mg/dL
   105 mEq/L
   143 mEq/L
   24.7 %
   8
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
   Hct
   24.7
   Cr
   0.8
   Glucose
   119
   88
   Other labs: Ca++:7.8 mg/dL, Mg++:1.4 mg/dL, PO4:2.0 mg/dL
   ALT/AST: 52/52, LDH 310, AP/T Bili: 80/0.4
   Free Ca: 1.06
   DIPSTICK URINALYSIS
                                    Blood
                                   Nitrite
                                   Protein
                                   Glucose
                                   Ketone
                                   Bilirub
                                   Urobiln
                                     pH
                                    Leuks
   [1][**2199-8-16**] 04:20AM
                                     TR
                                     NEG
                                     30
                                     NEG
                                     NEG
                                     NEG
                                     NEG
                                    8.5*
                                     NEG
   MTX
   [2][**2199-8-16**] 03:00AM
                                   2.61[1]
   [3][**2199-8-15**] 05:45PM
                                   7.2[1]
   No Images/Micro
   Assessment and Plan
   The patient is a 39-year-old woman, with history of type I diabetes
   since age 14 months, glomerulonephritis, kidney transplants in [**2174**] and
   [**2177**], and a double kidney and pancreas transplant on [**2188-11-20**], who has
   newly diagnosed EBV-driven CNS lymphoma.
   # EBV-Derived CNS Lymphoma
   Identified by biopsy. Being treated per plan by Drs. [**Last Name (STitle) 2351**] and
   [**Name5 (PTitle) 4292**].
   - IV high-dose methotrexate, and leucovorin rescue started on the onc
   floor; we are now alkalinizing urine and initiating CVVH after HD was
   done on the floor
   - check LFTs for hepatoxicity
   - monitor for GI sx, HA, N/V/D, SOB, joint pain, myalgias in the
   setting of high-dose MTX
   - continue leucovorin rescue per heme/onc orders
   - bicarbonate per heme/onc orders
   - antiemetics, supportive care
   .
   # Encephalopathy
   Some of her neurologic impairment may be residual effects of EBV
   meningoencephalitis, but [**Doctor Last Name 10280**] outpatient note suggests more likely
   to be lymphoma effects. Dr.[**Name (NI) 10281**] outpatient note suggests
   prominent features are memory impairment and emotional lability. Dr.
   [**Last Name (STitle) 2351**] initial note suggested methylphenidate as a possible aid to
   improved cognition; at this point, agitation while on CVVH/HD has been
   a bigger issue than slowing per report of the floor team, and would
   hold off on a stimulant until this phase is completed.
   .
   # s/p Pancreas-kidney transplant: However, transplanted kidney has
   marginal function but she is still making urine. Estimated creatinine
   clearance has been 20-25 cc/min/m2. Pancreas working fine; diabetes no
   longer an issue.
   - hold CellCept evidently per earlier recs; check in w renal transplant
   re timing of restarting this
   - continue prednisone 4mg daily
   - cont sodium bicarb 1300 PO Q6
   - follow up renal recommendations; renal transplant team is following
   and managing CVVH
   .
   # Hypertension
   - continue Atenolol 100 daily
   - continue amlodipine 5mg daily
   .
   ICU Care
   Nutrition: Full
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT: SQ Hep
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: Maintain on ICU pending onc recs
References
   1. JavaScript:parent.POPUP(self,%22_WEBTAG=_17%22);
   2. JavaScript:parent.POPUP(self,%22_WEBTAG=_19%22);
   3. JavaScript:parent.POPUP(self,%22_WEBTAG=_20%22);
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 PICC LINE - START [**2199-8-15**] 06:50 PM
   Placed in IR [**2199-8-14**]
 DIALYSIS CATHETER - START [**2199-8-15**] 06:50 PM
   [**2199-8-15**]:
   - urine successfully alkalinized with pH > 7.5.  Stopped bicarb drip.
   - continued cvvh
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-16**] 06:50 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.2
C (97.2
   HR: 74 (69 - 113) bpm
   BP: 147/79(96) {107/66(76) - 168/107(121)} mmHg
   RR: 16 (8 - 25) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 53 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                    755 mL
                                                                    701 mL
   PO:
             60 mL
   TF:
   IVF:
                                                                    755 mL
                                                                    641 mL
   Blood products:
   Total out:
                                                                    672 mL
                                                                  1,008 mL
   Urine:
                                                                    400 mL
                                                                  1,000 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                     83 mL
                                                                   -307 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   VBG: 7.48/43/35/28/
   Physical Examination
   GEN: Sitting in bed, poor eye-contact, NAD
   [**Name2 (NI) 1824**]: PERRL, [**Name (NI) **] but with several beats of nystagmus with gaze in
   both directions, O/P clear
   Neck: supple, no LAD, no JVD
   CV: RRR no m/g/r
   PULM: CTAB no w/r/r
   ABD: S/NT/ND normoactive bowel sounds
   EXT: no c/c/e, fistula in LUE, no palpable thrill
   Neuro: AAOx3, CN II-XII intact, normal sensory and motor exam
   SKIN: mild alopecia
   Labs / Radiology
   522
   8
   88 mg/dL
   0.8 mg/dL
   28 mEq/L
   3.5 mEq/L
   5 mg/dL
   105 mEq/L
   143 mEq/L
   24.7 %
   8
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
   Hct
   24.7
   Cr
   0.8
   Glucose
   119
   88
   Other labs: Ca++:7.8 mg/dL, Mg++:1.4 mg/dL, PO4:2.0 mg/dL
   ALT/AST: 52/52, LDH 310, AP/T Bili: 80/0.4
   Free Ca: 1.06
   DIPSTICK URINALYSIS
                                    Blood
                                   Nitrite
                                   Protein
                                   Glucose
                                   Ketone
                                   Bilirub
                                   Urobiln
                                     pH
                                    Leuks
   [1][**2199-8-16**] 04:20AM
                                     TR
                                     NEG
                                     30
                                     NEG
                                     NEG
                                     NEG
                                     NEG
                                    8.5*
                                     NEG
   MTX
   [2][**2199-8-16**] 03:00AM
                                   2.61[1]
   [3][**2199-8-15**] 05:45PM
                                   7.2[1]
   No Images/Micro
   Assessment and Plan
   The patient is a 39-year-old woman, with history of type I diabetes
   since age 14 months, glomerulonephritis, kidney transplants in [**2174**] and
   [**2177**], and a double kidney and pancreas transplant on [**2188-11-20**], who has
   newly diagnosed EBV-driven CNS lymphoma.
   # EBV-Derived CNS Lymphoma
   Identified by biopsy. Being treated per plan by Drs. [**Last Name (STitle) 2351**] and
   [**Name5 (PTitle) 4292**].
   - IV high-dose methotrexate, and leucovorin rescue started on the onc
   floor; we are now alkalinizing urine and initiating CVVH after HD was
   done on the floor
   - check LFTs for hepatoxicity
   - monitor for GI sx, HA, N/V/D, SOB, joint pain, myalgias in the
   setting of high-dose MTX
   - continue leucovorin rescue per heme/onc orders
   - bicarbonate per heme/onc orders
   - antiemetics, supportive care
   .
   # Encephalopathy
   Some of her neurologic impairment may be residual effects of EBV
   meningoencephalitis, but [**Doctor Last Name 10280**] outpatient note suggests more likely
   to be lymphoma effects. Dr.[**Name (NI) 10281**] outpatient note suggests
   prominent features are memory impairment and emotional lability. Dr.
   [**Last Name (STitle) 2351**] initial note suggested methylphenidate as a possible aid to
   improved cognition; at this point, agitation while on CVVH/HD has been
   a bigger issue than slowing per report of the floor team, and would
   hold off on a stimulant until this phase is completed.
   .
   # s/p Pancreas-kidney transplant: However, transplanted kidney has
   marginal function but she is still making urine. Estimated creatinine
   clearance has been 20-25 cc/min/m2. Pancreas working fine; diabetes no
   longer an issue.
   - hold CellCept evidently per earlier recs; check in w renal transplant
   re timing of restarting this
   - continue prednisone 4mg daily
   - cont sodium bicarb 1300 PO Q6
   - follow up renal recommendations; renal transplant team is following
   and managing CVVH
   .
   # Hypertension
   - continue Atenolol 100 daily
   - continue amlodipine 5mg daily
   .
   ICU Care
   Nutrition: Full
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT: SQ Hep
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: Maintain on ICU pending onc recs
References
   1. JavaScript:parent.POPUP(self,%22_WEBTAG=_17%22);
   2. JavaScript:parent.POPUP(self,%22_WEBTAG=_19%22);
   3. JavaScript:parent.POPUP(self,%22_WEBTAG=_20%22);<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 39-year-old woman with a complex medical history, including type I diabetes, glomerulonephritis, kidney transplants, and a double kidney and pancreas transplant. She has been diagnosed with EBV-driven CNS lymphoma and is currently receiving treatment, including high-dose methotrexate and leucovorin rescue.

The patient's current vital signs are:

* Temperature: 36.9°C (98.4°F)
* Heart rate: 74 beats per minute (bpm)
* Blood pressure: 147/79 mmHg
* Respiratory rate: 16 inspirations per minute
* Oxygen saturation: 98%
* Heart rhythm: Sinus rhythm

The patient's physical examination is notable for:

* Poor eye contact
* Mild alopecia
* Normal sensory and motor exam
* No palpable thrill in the extremities

Laboratory results show:

* Hemoglobin: 24.7 g/dL
* Creatinine: 0.8 mg/dL
* Glucose: 119 mg/dL
* Calcium: 7.8 mg/dL
* Magnesium: 1.4 mg/dL
* Phosphate: 2.0 mg/dL
* ALT/AST: 52/52 IU/L
* LDH: 310 IU/L
* AP/T Bili: 80/0.4 IU/L

The patient's urinalysis shows:

* pH: 8.5
* Leukocytes: negative
* Nitrite: negative
* Protein: 30 mg/dL
* Glucose: negative
* Ketone: negative
* Bilirubin: negative
* Urobilin: negative

The patient's condition is stable, with no significant changes in her vital signs or laboratory results. However, she is at risk for complications related to her cancer treatment, including:

* Hepatotoxicity from high-dose methotrexate
* Gastrointestinal side effects, such as nausea, vomiting, and diarrhea
* Hematological side effects, such as neutropenia and thrombocytopenia
* Infections, particularly central nervous system infections

The patient's medical history and current treatment plan also place her at risk for:

* Hypertension, which is currently being managed with medication
* Diabetes, which is no longer an issue due to her pancreas transplant
* Kidney function decline, which is being monitored closely

Overall, the patient's condition is complex and requires close monitoring and management to prevent complications and optimize her outcomes."
114163.0,216412,2199-08-16 07:05:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 PICC LINE - START [**2199-8-15**] 06:50 PM
   Placed in IR [**2199-8-14**]
 DIALYSIS CATHETER - START [**2199-8-15**] 06:50 PM
   [**2199-8-15**]:
   - urine successfully alkalinized with pH > 7.5.  Stopped bicarb drip.
   - continued cvvh
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-16**] 06:50 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.2
C (97.2
   HR: 74 (69 - 113) bpm
   BP: 147/79(96) {107/66(76) - 168/107(121)} mmHg
   RR: 16 (8 - 25) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 53 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                    755 mL
                                                                    701 mL
   PO:
             60 mL
   TF:
   IVF:
                                                                    755 mL
                                                                    641 mL
   Blood products:
   Total out:
                                                                    672 mL
                                                                  1,008 mL
   Urine:
                                                                    400 mL
                                                                  1,000 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                     83 mL
                                                                   -307 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   VBG: 7.48/43/35/28/
   Physical Examination
   GEN: Sitting in bed, poor eye-contact, NAD
   [**Name2 (NI) 1824**]: PERRL, [**Name (NI) **] but with several beats of nystagmus with gaze in
   both directions, O/P clear
   Neck: supple, no LAD, no JVD
   CV: RRR no m/g/r
   PULM: CTAB no w/r/r
   ABD: S/NT/ND normoactive bowel sounds
   EXT: no c/c/e, fistula in LUE, no palpable thrill
   Neuro: AAOx3, CN II-XII intact, normal sensory and motor exam
   SKIN: mild alopecia
   Labs / Radiology
   522
   8
   88 mg/dL
   0.8 mg/dL
   28 mEq/L
   3.5 mEq/L
   5 mg/dL
   105 mEq/L
   143 mEq/L
   24.7 %
   8
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
   Hct
   24.7
   Cr
   0.8
   Glucose
   119
   88
   Other labs: Ca++:7.8 mg/dL, Mg++:1.4 mg/dL, PO4:2.0 mg/dL
   ALT/AST: 52/52, LDH 310, AP/T Bili: 80/0.4
   Free Ca: 1.06
   DIPSTICK URINALYSIS
                                    Blood
                                   Nitrite
                                   Protein
                                   Glucose
                                   Ketone
                                   Bilirub
                                   Urobiln
                                     pH
                                    Leuks
   [1][**2199-8-16**] 04:20AM
                                     TR
                                     NEG
                                     30
                                     NEG
                                     NEG
                                     NEG
                                     NEG
                                    8.5*
                                     NEG
   No Images/Micro
   Assessment and Plan
   The patient is a 39-year-old woman, with history of type I diabetes
   since age 14 months, glomerulonephritis, kidney transplants in [**2174**] and
   [**2177**], and a double kidney and pancreas transplant on [**2188-11-20**], who has
   newly diagnosed EBV-driven CNS lymphoma.
   # EBV-Derived CNS Lymphoma
   Identified by biopsy. Being treated per plan by Drs. [**Last Name (STitle) 2351**] and
   [**Name5 (PTitle) 4292**].
   - IV high-dose methotrexate, and leucovorin rescue started on the onc
   floor; we are now alkalinizing urine and initiating CVVH after HD was
   done on the floor
   - continue leucovorin rescue per heme/onc orders
   - bicarbonate per heme/onc orders
   - antiemetics, supportive care
   .
   # Encephalopathy
   Some of her neurologic impairment may be residual effects of EBV
   meningoencephalitis, but [**Doctor Last Name 10280**] outpatient note suggests more likely
   to be lymphoma effects. Dr.[**Name (NI) 10281**] outpatient note suggests
   prominent features are memory impairment and emotional lability. Dr.
   [**Last Name (STitle) 2351**] initial note suggested methylphenidate as a possible aid to
   improved cognition; at this point, agitation while on CVVH/HD has been
   a bigger issue than slowing per report of the floor team, and would
   hold off on a stimulant until this phase is completed.
   .
   # s/p Pancreas-kidney transplant: However, transplanted kidney has
   marginal function but she is still making urine. Estimated creatinine
   clearance has been 20-25 cc/min/m2. Pancreas working fine; diabetes no
   longer an issue.
   - hold CellCept evidently per earlier recs; check in w renal transplant
   re timing of restarting this
   - continue prednisone 4mg daily
   - cont sodium bicarb 1300 PO Q6
   - follow up renal recommendations; renal transplant team is following
   and managing CVVH
   .
   # Hypertension
   - continue Atenolol 100 daily
   - continue amlodipine 5mg daily
   .
   # Proph: Hep SQ, PPI (on at home as with chronic prednisone)
   .
   # Full Code
   ICU Care
   Nutrition: Full
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT: SQ Hep
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
References
   1. JavaScript:parent.POPUP(self,%22_WEBTAG=_17%22);
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 PICC LINE - START [**2199-8-15**] 06:50 PM
   Placed in IR [**2199-8-14**]
 DIALYSIS CATHETER - START [**2199-8-15**] 06:50 PM
   [**2199-8-15**]:
   - urine successfully alkalinized with pH > 7.5.  Stopped bicarb drip.
   - continued cvvh
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-16**] 06:50 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.2
C (97.2
   HR: 74 (69 - 113) bpm
   BP: 147/79(96) {107/66(76) - 168/107(121)} mmHg
   RR: 16 (8 - 25) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 53 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                    755 mL
                                                                    701 mL
   PO:
             60 mL
   TF:
   IVF:
                                                                    755 mL
                                                                    641 mL
   Blood products:
   Total out:
                                                                    672 mL
                                                                  1,008 mL
   Urine:
                                                                    400 mL
                                                                  1,000 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                     83 mL
                                                                   -307 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   VBG: 7.48/43/35/28/
   Physical Examination
   GEN: Sitting in bed, poor eye-contact, NAD
   [**Name2 (NI) 1824**]: PERRL, [**Name (NI) **] but with several beats of nystagmus with gaze in
   both directions, O/P clear
   Neck: supple, no LAD, no JVD
   CV: RRR no m/g/r
   PULM: CTAB no w/r/r
   ABD: S/NT/ND normoactive bowel sounds
   EXT: no c/c/e, fistula in LUE, no palpable thrill
   Neuro: AAOx3, CN II-XII intact, normal sensory and motor exam
   SKIN: mild alopecia
   Labs / Radiology
   522
   8
   88 mg/dL
   0.8 mg/dL
   28 mEq/L
   3.5 mEq/L
   5 mg/dL
   105 mEq/L
   143 mEq/L
   24.7 %
   8
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
   Hct
   24.7
   Cr
   0.8
   Glucose
   119
   88
   Other labs: Ca++:7.8 mg/dL, Mg++:1.4 mg/dL, PO4:2.0 mg/dL
   ALT/AST: 52/52, LDH 310, AP/T Bili: 80/0.4
   Free Ca: 1.06
   DIPSTICK URINALYSIS
                                    Blood
                                   Nitrite
                                   Protein
                                   Glucose
                                   Ketone
                                   Bilirub
                                   Urobiln
                                     pH
                                    Leuks
   [1][**2199-8-16**] 04:20AM
                                     TR
                                     NEG
                                     30
                                     NEG
                                     NEG
                                     NEG
                                     NEG
                                    8.5*
                                     NEG
   No Images/Micro
   Assessment and Plan
   The patient is a 39-year-old woman, with history of type I diabetes
   since age 14 months, glomerulonephritis, kidney transplants in [**2174**] and
   [**2177**], and a double kidney and pancreas transplant on [**2188-11-20**], who has
   newly diagnosed EBV-driven CNS lymphoma.
   # EBV-Derived CNS Lymphoma
   Identified by biopsy. Being treated per plan by Drs. [**Last Name (STitle) 2351**] and
   [**Name5 (PTitle) 4292**].
   - IV high-dose methotrexate, and leucovorin rescue started on the onc
   floor; we are now alkalinizing urine and initiating CVVH after HD was
   done on the floor
   - continue leucovorin rescue per heme/onc orders
   - bicarbonate per heme/onc orders
   - antiemetics, supportive care
   .
   # Encephalopathy
   Some of her neurologic impairment may be residual effects of EBV
   meningoencephalitis, but [**Doctor Last Name 10280**] outpatient note suggests more likely
   to be lymphoma effects. Dr.[**Name (NI) 10281**] outpatient note suggests
   prominent features are memory impairment and emotional lability. Dr.
   [**Last Name (STitle) 2351**] initial note suggested methylphenidate as a possible aid to
   improved cognition; at this point, agitation while on CVVH/HD has been
   a bigger issue than slowing per report of the floor team, and would
   hold off on a stimulant until this phase is completed.
   .
   # s/p Pancreas-kidney transplant: However, transplanted kidney has
   marginal function but she is still making urine. Estimated creatinine
   clearance has been 20-25 cc/min/m2. Pancreas working fine; diabetes no
   longer an issue.
   - hold CellCept evidently per earlier recs; check in w renal transplant
   re timing of restarting this
   - continue prednisone 4mg daily
   - cont sodium bicarb 1300 PO Q6
   - follow up renal recommendations; renal transplant team is following
   and managing CVVH
   .
   # Hypertension
   - continue Atenolol 100 daily
   - continue amlodipine 5mg daily
   .
   # Proph: Hep SQ, PPI (on at home as with chronic prednisone)
   .
   # Full Code
   ICU Care
   Nutrition: Full
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT: SQ Hep
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
References
   1. JavaScript:parent.POPUP(self,%22_WEBTAG=_17%22);<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 39-year-old woman with a history of type I diabetes, glomerulonephritis, kidney transplants, and a double kidney and pancreas transplant. She has been diagnosed with EBV-driven CNS lymphoma and is currently undergoing treatment with IV high-dose methotrexate and leucovorin rescue.

The patient's vital signs are stable, with a temperature of 36.9°C, heart rate of 74 beats per minute, and blood pressure of 147/79 mmHg. Her respiratory rate is 16 breaths per minute, and her oxygen saturation is 98%. Her neurological examination is normal, with intact cranial nerves and normal sensory and motor function.

The patient's laboratory results show elevated levels of creatinine, urea, and electrolytes, indicating kidney dysfunction. Her liver function tests are normal, but her serum glucose level is elevated at 119 mg/dL. Her urinalysis shows blood and protein in the urine, but no signs of infection or inflammation.

The patient's medical history includes a history of kidney transplants, pancreas transplant, and a diagnosis of EBV-driven CNS lymphoma. She is currently receiving treatment for her lymphoma and has been placed on full code status.

Potential medical complications that can arise based on this information include:

1. Infection: The patient's immunocompromised state due to her lymphoma treatment and kidney transplant may increase her risk of developing infections.
2. Kidney failure: The patient's kidney function is marginal, and she is at risk of developing acute kidney injury or chronic kidney disease.
3. Hypertension: The patient's blood pressure is elevated, and she is at risk of developing hypertension-related complications such as heart failure, stroke, or kidney damage.
4. Hyperglycemia: The patient's elevated serum glucose level may indicate hyperglycemia, which can lead to complications such as diabetic ketoacidosis or hyperosmolar hyperglycemic nonketotic syndrome.
5. Neurological complications: The patient's lymphoma treatment may cause neurological complications such as seizures, encephalopathy, or cognitive impairment.
6. Gastrointestinal complications: The patient's lymphoma treatment may cause gastrointestinal complications such as nausea, vomiting, or diarrhea.
7. Hematological complications: The patient's lymphoma treatment may cause hematological complications such as anemia, neutropenia, or thrombocytopenia.

Based on this information, it is recommended that the patient receive close monitoring and management of her vital signs, laboratory results, and medical complications to prevent or minimize potential adverse effects."
114163.0,216412,2199-08-16 12:01:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Lymphoma
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
 PICC LINE - START [**2199-8-15**] 06:50 PM
   Placed in IR [**2199-8-14**]
 DIALYSIS CATHETER - START [**2199-8-15**] 06:50 PM
   -HCO3- gtt stopped with urine alkaline
   History obtained from [**Hospital 15**] Medical records
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue
   Flowsheet Data as of  [**2199-8-16**] 12:01 PM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.2
C (97.2
   HR: 94 (69 - 113) bpm
   BP: 146/91(104) {107/66(76) - 168/113(121)} mmHg
   RR: 16 (8 - 25) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 53 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                    755 mL
                                                                  2,207 mL
   PO:
             480 mL
   TF:
   IVF:
                                                                    755 mL
                                                                  1,727 mL
   Blood products:
   Total out:
                                                                    672 mL
                                                                  2,300 mL
   Urine:
                                                                    400 mL
                                                                  2,100 mL
   NG:
   200 mL
   Stool:
   Drains:
   Balance:
                                                                     83 mL
                                                                    -93 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///27/
   Physical Examination
   Cardiovascular: (S1: Normal), (S2: Distant)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Percussion: Resonant : ), (Breath Sounds: Clear :
   )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Follows simple commands, Responds to: Verbal stimuli,
   Oriented (to): person, place, time, Movement: Not assessed, Tone: Not
   assessed, poor word finding
   Labs / Radiology
   110 mg/dL
   1.0 mg/dL
   27 mEq/L
   3.7 mEq/L
   4 mg/dL
   103 mEq/L
   141 mEq/L
   24.7 %
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
                             [**2199-8-16**]  09:08 AM
   Hct
   24.7
   Cr
   0.8
   1.0
   Glucose
   119
   88
   110
   Other labs: Ca++:9.2 mg/dL, Mg++:1.4 mg/dL, PO4:1.7 mg/dL
   Fluid analysis / Other labs: Urine pH=8.0
   Assessment and Plan
   39 yo female with Type I DM--now s/p renal transplant x3 and pancreatic
   transplant x1 who has post transplant course now complicated by CNS
   Lymphoma with previous identification of EBV.  She is undergoing MTX
   treatment and in the setting of CVVH required for maintenance of renal
   protection patient is in ICU for maintenance of CVVH therapy in the
   setting of renal transplant.
   1) LYMPHOMA (CANCER, MALIGNANT NEOPLASM, LYMPHOID)-
   -Continue MTX per oncology service
   -Will continue CVVH per renal service
   -WIll continue HCO3- oral
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 33 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Lymphoma
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
 PICC LINE - START [**2199-8-15**] 06:50 PM
   Placed in IR [**2199-8-14**]
 DIALYSIS CATHETER - START [**2199-8-15**] 06:50 PM
   -HCO3- gtt stopped with urine alkaline
   History obtained from [**Hospital 15**] Medical records
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue
   Flowsheet Data as of  [**2199-8-16**] 12:01 PM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.2
C (97.2
   HR: 94 (69 - 113) bpm
   BP: 146/91(104) {107/66(76) - 168/113(121)} mmHg
   RR: 16 (8 - 25) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 53 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                    755 mL
                                                                  2,207 mL
   PO:
             480 mL
   TF:
   IVF:
                                                                    755 mL
                                                                  1,727 mL
   Blood products:
   Total out:
                                                                    672 mL
                                                                  2,300 mL
   Urine:
                                                                    400 mL
                                                                  2,100 mL
   NG:
   200 mL
   Stool:
   Drains:
   Balance:
                                                                     83 mL
                                                                    -93 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///27/
   Physical Examination
   Cardiovascular: (S1: Normal), (S2: Distant)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Percussion: Resonant : ), (Breath Sounds: Clear :
   )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Follows simple commands, Responds to: Verbal stimuli,
   Oriented (to): person, place, time, Movement: Not assessed, Tone: Not
   assessed, poor word finding
   Labs / Radiology
   110 mg/dL
   1.0 mg/dL
   27 mEq/L
   3.7 mEq/L
   4 mg/dL
   103 mEq/L
   141 mEq/L
   24.7 %
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
                             [**2199-8-16**]  09:08 AM
   Hct
   24.7
   Cr
   0.8
   1.0
   Glucose
   119
   88
   110
   Other labs: Ca++:9.2 mg/dL, Mg++:1.4 mg/dL, PO4:1.7 mg/dL
   Fluid analysis / Other labs: Urine pH=8.0
   Assessment and Plan
   39 yo female with Type I DM--now s/p renal transplant x3 and pancreatic
   transplant x1 who has post transplant course now complicated by CNS
   Lymphoma with previous identification of EBV.  She is undergoing MTX
   treatment and in the setting of CVVH required for maintenance of renal
   protection patient is in ICU for maintenance of CVVH therapy in the
   setting of renal transplant.
   1) LYMPHOMA (CANCER, MALIGNANT NEOPLASM, LYMPHOID)-
   -Continue MTX per oncology service
   -Will continue CVVH per renal service
   -WIll continue HCO3- oral
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 33 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 39-year-old female with a history of type I diabetes mellitus, who has undergone three renal transplants and one pancreatic transplant. She is currently in the ICU due to complications from post-transplant course, including central nervous system (CNS) lymphoma, which has been identified as Epstein-Barr virus (EBV) positive. She is receiving methotrexate (MTX) treatment and is on continuous veno-venous hemofiltration (CVVH) for renal protection.

Current vital signs include a temperature of 36.9°C (98.4°F), heart rate of 94 beats per minute, blood pressure of 146/91 mmHg, respiratory rate of 16 breaths per minute, and oxygen saturation of 98%. Her physical examination reveals a soft, non-tender abdomen, and her neurologic examination shows that she follows simple commands, responds to verbal stimuli, and is oriented to person, place, and time.

Lab results show:

* Hemoglobin: 110 mg/dL
* Hematocrit: 24.7%
* Creatinine: 0.8 mg/dL
* Glucose: 119 mg/dL
* Calcium: 9.2 mg/dL
* Magnesium: 1.4 mg/dL
* Phosphate: 1.7 mg/dL
* Urine pH: 8.0

Potential medical complications that can arise include:

* Further progression of CNS lymphoma, which can lead to increased intracranial pressure, seizures, and neurological deficits
* Renal failure, which can lead to electrolyte imbalances, acidosis, and cardiovascular instability
* Infections, such as ventilator-associated pneumonia (VAP) or catheter-related bloodstream infections, which can lead to sepsis and organ dysfunction
* Hyperglycemia, which can lead to ketoacidosis, hyperosmolar non-ketotic syndrome, or even coma
* Electrolyte imbalances, such as hypokalemia, hypomagnesemia, or hypophosphatemia, which can lead to cardiac arrhythmias, muscle weakness, or seizures
* Thrombocytopenia, which can increase the risk of bleeding complications
* Gastrointestinal bleeding, which can be caused by stress ulcers or anticoagulation therapy

Close monitoring of the patient's vital signs, laboratory results, and clinical condition is essential to prevent or promptly manage these potential complications."
114163.0,216412,2199-08-17 06:31:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - renal recs: cont CVVH, check MTX level at 3am. If <0.1, can stop
   CVVH. check CBC lytes and VBG. replete phos with K phos 30mM. hold MMF
   if WBC <3.0, otherwise on discharge restart MMF at 500mg [**Hospital1 7**]. No bicarb
   necessary as pt is on CVVH
   - onc recs: if MTX <0.1, can stop CVVH. wondering if pt can be
   electively admitted to [**Hospital Unit Name 1**] next time for CVVH. pt can be d/c'd home
   directly from [**Hospital Unit Name 1**] when not requiring CVVH
   - renal and onc had conflicting recs: renal wants to stop CVVH when MTX
   level <1, onc wants <0.1. Renal is thinking about long-session HD for
   next time but onc wants elective [**Hospital Unit Name 1**] admission next time. renal wanted
   to run even I/O, but onc wants to run negative.
   - cvvh continued as MTX level was 2.61
   - urine ph has been above 7.5
   - pt was teary eyed and anxious all night, relieved somewhat by ativan
   and chocolate, and comfort by nurse all night
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-17**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 35.8
C (96.4
   HR: 113 (75 - 113) bpm
   BP: 160/82(101) {138/70(92) - 165/136(141)} mmHg
   RR: 15 (15 - 31) insp/min
   SpO2: 98%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 55 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                  5,311 mL
                                                                  1,068 mL
   PO:
                                                                    960 mL
                                                                     80 mL
   TF:
   IVF:
                                                                  4,351 mL
                                                                    988 mL
   Blood products:
   Total out:
                                                                  6,054 mL
                                                                  1,444 mL
   Urine:
                                                                  4,050 mL
                                                                  1,000 mL
   NG:
                                                                    200 mL
   Stool:
                                                                    100 mL
   Drains:
   Balance:
                                                                   -743 mL
                                                                   -376 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///24/
   Physical Examination
   GEN: lying in bed, poor eye-contact, NAD
   [**Name2 (NI) 1824**]: PERRL, [**Name (NI) **], O/P clear
   Neck: supple, no LAD, no JVD
   CV: RRR no m/g/r
   PULM: CTAB no w/r/r
   ABD: S/NT/ND normoactive bowel sounds
   EXT: no c/c/e, fistula in LUE, no palpable thrill
   Neuro: AAOx3, CN II-XII intact, normal sensory and motor exam
   SKIN: mild alopecia
   Labs / Radiology
   378 K/uL
   8.1 g/dL
   108 mg/dL
   1.0 mg/dL
   24 mEq/L
   3.8 mEq/L
   5 mg/dL
   99 mEq/L
   135 mEq/L
   23.9 %
   6.9 K/uL
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
                             [**2199-8-16**]  09:08 AM
                             [**2199-8-16**]  02:41 PM
                             [**2199-8-16**]  09:07 PM
                             [**2199-8-17**]  02:20 AM
   WBC
   9.2
   6.9
   Hct
   24.7
   27.5
   23.9
   Plt
   478
   378
   Cr
   0.8
   1.0
   1.0
   1.0
   1.0
   Glucose
   119
   88
   110
   119
   115
   108
   Other labs:
   PT / PTT / INR:11.4/25.5/0.9,
   ALT / AST:108/101, Alk Phos / T Bili:67/0.3, Albumin:3.5 g/dL, LDH:334
   IU/L,
   Ca++:8.3 mg/dL, Mg++:1.5 mg/dL, PO4:2.3 mg/dL
   Methotrexate level: pending
   Micro: none
   Imaging: none
   Assessment and Plan
   The patient is a 39-year-old woman, with history of type I diabetes
   since age 14 months, glomerulonephritis, kidney transplants in [**2174**] and
   [**2177**], and a double kidney and pancreas transplant on [**2188-11-20**], who has
   newly diagnosed EBV-driven CNS lymphoma.
   # EBV-Derived CNS Lymphoma: Identified by biopsy. Being treated per
   plan by Drs. [**Last Name (STitle) 2351**] and [**Name5 (PTitle) 4292**].
   - IV high-dose methotrexate, and leucovorin rescue started on the onc
   floor; we are now alkalinizing urine and initiating CVVH after HD was
   done on the floor
   - monitor for GI sx, elevated LFTs, HA, N/V/D, SOB, joint pain,
   myalgias in the setting of high-dose MTX
   - continue leucovorin rescue per heme/onc orders
   - continue cvvh
   - d/c bicarbonate
   - antiemetics, supportive care
   - goal urine pH>7.5
   - check pm methotrexate level, can d/c pt if MTX<0.1
   .
   # Elevated LFT: LFT higher today compared to [**8-14**]. most likely
   secondary to methotrexate. Pt is hepatitis C positive since [**2185**]. [**Last Name (un) **]
   and B neg. Unclear if pt was ever treated for hepC.
   - increase leucovorin dose per Dr. [**Last Name (STitle) 2351**]
   - continue to monitor
   - will need to get hep C viral load checked as outpatient
   - If continues to rise, RUQ US to rule out cholecystitis or liver
   pathology
   .
   # Encephalopathy: Some of her neurologic impairment may be residual
   effects of EBV meningoencephalitis, but [**Doctor Last Name 10280**] outpatient note
   suggests more likely to be lymphoma effects. Dr.[**Name (NI) 10281**] outpatient
   note suggests prominent features are memory impairment and emotional
   lability. Dr. [**Last Name (STitle) 2351**] initial note suggested methylphenidate as a possible
   aid to improved cognition; at this point, agitation while on CVVH/HD
   has been a bigger issue than slowing per report of the floor team, and
   would hold off on a stimulant until this phase is completed.
   - continue to monitor mental status regularly
   .
   # s/p Pancreas-kidney transplant: transplanted kidney has marginal
   function but she is still making urine. Estimated creatinine clearance
   has been 20-25 cc/min/m2. Pancreas working fine; diabetes no longer an
   issue.
   - hold MMF if WBC <3.0, otherwise on discharge restart MMF at 500mg [**Hospital1 7**]
   - continue prednisone 4mg daily
   - d/c sodium bicarb 1300 PO Q6
   - follow up renal recommendations; renal transplant team is following
   and managing CVVH
   .
   # Hypertension:
   - continue Atenolol 100 daily
   - continue amlodipine 5mg daily
   .
   # Type I DM: s/p kidney / pancreas double transplant. DM not an issue
   any more
   - not on ISS, and glucose wnl
   - continue to monitor glucose
   .
   # Anxiety:
   - ativan prn
   - SW consult if pt goes to floor
   ICU Care
   Nutrition: Full
   Glycemic Control:  not on ISS, glucose normal
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT: SQ Hep
   Stress ulcer: PPI
   VAP:  none indicated
   Comments:
   Communication:  Comments: patient
   Code status: Full code
   Disposition: can discharge from [**Hospital Unit Name 1**] after MTX is <0.1
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - renal recs: cont CVVH, check MTX level at 3am. If <0.1, can stop
   CVVH. check CBC lytes and VBG. replete phos with K phos 30mM. hold MMF
   if WBC <3.0, otherwise on discharge restart MMF at 500mg [**Hospital1 7**]. No bicarb
   necessary as pt is on CVVH
   - onc recs: if MTX <0.1, can stop CVVH. wondering if pt can be
   electively admitted to [**Hospital Unit Name 1**] next time for CVVH. pt can be d/c'd home
   directly from [**Hospital Unit Name 1**] when not requiring CVVH
   - renal and onc had conflicting recs: renal wants to stop CVVH when MTX
   level <1, onc wants <0.1. Renal is thinking about long-session HD for
   next time but onc wants elective [**Hospital Unit Name 1**] admission next time. renal wanted
   to run even I/O, but onc wants to run negative.
   - cvvh continued as MTX level was 2.61
   - urine ph has been above 7.5
   - pt was teary eyed and anxious all night, relieved somewhat by ativan
   and chocolate, and comfort by nurse all night
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-17**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 35.8
C (96.4
   HR: 113 (75 - 113) bpm
   BP: 160/82(101) {138/70(92) - 165/136(141)} mmHg
   RR: 15 (15 - 31) insp/min
   SpO2: 98%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 55 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                  5,311 mL
                                                                  1,068 mL
   PO:
                                                                    960 mL
                                                                     80 mL
   TF:
   IVF:
                                                                  4,351 mL
                                                                    988 mL
   Blood products:
   Total out:
                                                                  6,054 mL
                                                                  1,444 mL
   Urine:
                                                                  4,050 mL
                                                                  1,000 mL
   NG:
                                                                    200 mL
   Stool:
                                                                    100 mL
   Drains:
   Balance:
                                                                   -743 mL
                                                                   -376 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///24/
   Physical Examination
   GEN: lying in bed, poor eye-contact, NAD
   [**Name2 (NI) 1824**]: PERRL, [**Name (NI) **], O/P clear
   Neck: supple, no LAD, no JVD
   CV: RRR no m/g/r
   PULM: CTAB no w/r/r
   ABD: S/NT/ND normoactive bowel sounds
   EXT: no c/c/e, fistula in LUE, no palpable thrill
   Neuro: AAOx3, CN II-XII intact, normal sensory and motor exam
   SKIN: mild alopecia
   Labs / Radiology
   378 K/uL
   8.1 g/dL
   108 mg/dL
   1.0 mg/dL
   24 mEq/L
   3.8 mEq/L
   5 mg/dL
   99 mEq/L
   135 mEq/L
   23.9 %
   6.9 K/uL
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
                             [**2199-8-16**]  09:08 AM
                             [**2199-8-16**]  02:41 PM
                             [**2199-8-16**]  09:07 PM
                             [**2199-8-17**]  02:20 AM
   WBC
   9.2
   6.9
   Hct
   24.7
   27.5
   23.9
   Plt
   478
   378
   Cr
   0.8
   1.0
   1.0
   1.0
   1.0
   Glucose
   119
   88
   110
   119
   115
   108
   Other labs:
   PT / PTT / INR:11.4/25.5/0.9,
   ALT / AST:108/101, Alk Phos / T Bili:67/0.3, Albumin:3.5 g/dL, LDH:334
   IU/L,
   Ca++:8.3 mg/dL, Mg++:1.5 mg/dL, PO4:2.3 mg/dL
   Methotrexate level: pending
   Micro: none
   Imaging: none
   Assessment and Plan
   The patient is a 39-year-old woman, with history of type I diabetes
   since age 14 months, glomerulonephritis, kidney transplants in [**2174**] and
   [**2177**], and a double kidney and pancreas transplant on [**2188-11-20**], who has
   newly diagnosed EBV-driven CNS lymphoma.
   # EBV-Derived CNS Lymphoma: Identified by biopsy. Being treated per
   plan by Drs. [**Last Name (STitle) 2351**] and [**Name5 (PTitle) 4292**].
   - IV high-dose methotrexate, and leucovorin rescue started on the onc
   floor; we are now alkalinizing urine and initiating CVVH after HD was
   done on the floor
   - monitor for GI sx, elevated LFTs, HA, N/V/D, SOB, joint pain,
   myalgias in the setting of high-dose MTX
   - continue leucovorin rescue per heme/onc orders
   - continue cvvh
   - d/c bicarbonate
   - antiemetics, supportive care
   - goal urine pH>7.5
   - check pm methotrexate level, can d/c pt if MTX<0.1
   .
   # Elevated LFT: LFT higher today compared to [**8-14**]. most likely
   secondary to methotrexate. Pt is hepatitis C positive since [**2185**]. [**Last Name (un) **]
   and B neg. Unclear if pt was ever treated for hepC.
   - increase leucovorin dose per Dr. [**Last Name (STitle) 2351**]
   - continue to monitor
   - will need to get hep C viral load checked as outpatient
   - If continues to rise, RUQ US to rule out cholecystitis or liver
   pathology
   .
   # Encephalopathy: Some of her neurologic impairment may be residual
   effects of EBV meningoencephalitis, but [**Doctor Last Name 10280**] outpatient note
   suggests more likely to be lymphoma effects. Dr.[**Name (NI) 10281**] outpatient
   note suggests prominent features are memory impairment and emotional
   lability. Dr. [**Last Name (STitle) 2351**] initial note suggested methylphenidate as a possible
   aid to improved cognition; at this point, agitation while on CVVH/HD
   has been a bigger issue than slowing per report of the floor team, and
   would hold off on a stimulant until this phase is completed.
   - continue to monitor mental status regularly
   .
   # s/p Pancreas-kidney transplant: transplanted kidney has marginal
   function but she is still making urine. Estimated creatinine clearance
   has been 20-25 cc/min/m2. Pancreas working fine; diabetes no longer an
   issue.
   - hold MMF if WBC <3.0, otherwise on discharge restart MMF at 500mg [**Hospital1 7**]
   - continue prednisone 4mg daily
   - d/c sodium bicarb 1300 PO Q6
   - follow up renal recommendations; renal transplant team is following
   and managing CVVH
   .
   # Hypertension:
   - continue Atenolol 100 daily
   - continue amlodipine 5mg daily
   .
   # Type I DM: s/p kidney / pancreas double transplant. DM not an issue
   any more
   - not on ISS, and glucose wnl
   - continue to monitor glucose
   .
   # Anxiety:
   - ativan prn
   - SW consult if pt goes to floor
   ICU Care
   Nutrition: Full
   Glycemic Control:  not on ISS, glucose normal
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT: SQ Hep
   Stress ulcer: PPI
   VAP:  none indicated
   Comments:
   Communication:  Comments: patient
   Code status: Full code
   Disposition: can discharge from [**Hospital Unit Name 1**] after MTX is <0.1<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 39-year-old woman with a history of type I diabetes, glomerulonephritis, kidney transplants, and a double kidney and pancreas transplant. She has newly diagnosed EBV-driven CNS lymphoma and is being treated with IV high-dose methotrexate and leucovorin rescue.

The patient's current condition is as follows:

* Renal function: The patient is on continuous venovenous hemofiltration (CVVH) and has a marginal function of her transplanted kidney, with an estimated creatinine clearance of 20-25 cc/min/m2.
* Hematological: The patient's white blood cell count is 6.9 K/uL, and her platelet count is 378 K/uL.
* Hepatic: The patient's liver function tests (LFTs) are elevated, likely secondary to methotrexate. She is hepatitis C positive and will need to get a viral load checked as an outpatient.
* Neurological: The patient has encephalopathy, which may be residual effects of EBV meningoencephalitis or lymphoma effects. She is being monitored for mental status regularly.
* Cardiovascular: The patient has hypertension, which is being managed with Atenolol and amlodipine.
* Endocrine: The patient has type I diabetes, which is no longer an issue since her pancreas transplant.

Potential medical complications that can arise:

* Gastrointestinal: The patient is at risk for gastrointestinal symptoms such as nausea, vomiting, and diarrhea due to high-dose methotrexate.
* Hepatotoxicity: The patient's elevated LFTs may worsen if she continues to receive high-dose methotrexate.
* Infection: The patient is at risk for infection due to her compromised immune system and the use of immunosuppressive medications.
* Neurological: The patient's encephalopathy may worsen if not properly managed.
* Renal: The patient's marginal function of her transplanted kidney may worsen if not properly managed.

The patient's plan of care includes:

* Continuing CVVH and monitoring for gastrointestinal symptoms, elevated LFTs, and haematological toxicity.
* Increasing leucovorin dose to manage methotrexate toxicity.
* Monitoring mental status regularly and holding off on stimulants until the patient's current phase is completed.
* Managing hypertension with Atenolol and amlodipine.
* Monitoring glucose levels and holding off on ISS.
* Providing supportive care and antiemetics as needed.
* Discharging the patient from the hospital after her methotrexate level is less than 0.1."
114163.0,216412,2199-08-17 06:31:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - renal and onc had conflicting recs: renal wants to stop CVVH when MTX
   level <1, onc wants <0.1. Renal is thinking about long-session HD for
   next time but onc wants elective [**Hospital Unit Name 1**] admission next time. renal wanted
   to run even I/O, but onc wants to run negative.
   - renal recs: cont CVVH, check MTX level at 3am. If <0.1, can stop
   CVVH. check CBC lytes and VBG. replete phos with K phos 30mM. hold MMF
   if WBC <3.0, otherwise on discharge restart MMF at 500mg [**Hospital1 7**]
   - onc recs: if MTX <0.1, can stop CVVH. wondering if pt can be
   electively admitted to [**Hospital Unit Name 1**] next time for CVVH. pt can be d/c'd home
   directly from [**Hospital Unit Name 1**] when not requiring CVVH
   - cvvh continued as MTX level was 2.61
   - urine ph has been above 7.5
   - pt was teary eyed and anxious all night, relieved somewhat by ativan
   and chocolate.
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-17**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 35.8
C (96.4
   HR: 113 (75 - 113) bpm
   BP: 160/82(101) {138/70(92) - 165/136(141)} mmHg
   RR: 15 (15 - 31) insp/min
   SpO2: 98%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 55 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                  5,311 mL
                                                                  1,068 mL
   PO:
                                                                    960 mL
                                                                     80 mL
   TF:
   IVF:
                                                                  4,351 mL
                                                                    988 mL
   Blood products:
   Total out:
                                                                  6,054 mL
                                                                  1,444 mL
   Urine:
                                                                  4,050 mL
                                                                  1,000 mL
   NG:
                                                                    200 mL
   Stool:
                                                                    100 mL
   Drains:
   Balance:
                                                                   -743 mL
                                                                   -376 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///24/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   378 K/uL
   8.1 g/dL
   108 mg/dL
   1.0 mg/dL
   24 mEq/L
   3.8 mEq/L
   5 mg/dL
   99 mEq/L
   135 mEq/L
   23.9 %
   6.9 K/uL
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
                             [**2199-8-16**]  09:08 AM
                             [**2199-8-16**]  02:41 PM
                             [**2199-8-16**]  09:07 PM
                             [**2199-8-17**]  02:20 AM
   WBC
   9.2
   6.9
   Hct
   24.7
   27.5
   23.9
   Plt
   478
   378
   Cr
   0.8
   1.0
   1.0
   1.0
   1.0
   Glucose
   119
   88
   110
   119
   115
   108
   Other labs:
   PT / PTT / INR:11.4/25.5/0.9, ALT / AST:108/101, Alk Phos / T
   Bili:67/0.3, Albumin:3.5 g/dL, LDH:334 IU/L, Ca++:8.3 mg/dL, Mg++:1.5
   mg/dL, PO4:2.3 mg/dL
   Assessment and Plan
 INEFFECTIVE COPING
 LYMPHOMA (CANCER, MALIGNANT NEOPLASM, LYMPHOID)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - renal and onc had conflicting recs: renal wants to stop CVVH when MTX
   level <1, onc wants <0.1. Renal is thinking about long-session HD for
   next time but onc wants elective [**Hospital Unit Name 1**] admission next time. renal wanted
   to run even I/O, but onc wants to run negative.
   - renal recs: cont CVVH, check MTX level at 3am. If <0.1, can stop
   CVVH. check CBC lytes and VBG. replete phos with K phos 30mM. hold MMF
   if WBC <3.0, otherwise on discharge restart MMF at 500mg [**Hospital1 7**]
   - onc recs: if MTX <0.1, can stop CVVH. wondering if pt can be
   electively admitted to [**Hospital Unit Name 1**] next time for CVVH. pt can be d/c'd home
   directly from [**Hospital Unit Name 1**] when not requiring CVVH
   - cvvh continued as MTX level was 2.61
   - urine ph has been above 7.5
   - pt was teary eyed and anxious all night, relieved somewhat by ativan
   and chocolate.
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-17**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 35.8
C (96.4
   HR: 113 (75 - 113) bpm
   BP: 160/82(101) {138/70(92) - 165/136(141)} mmHg
   RR: 15 (15 - 31) insp/min
   SpO2: 98%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 55 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                  5,311 mL
                                                                  1,068 mL
   PO:
                                                                    960 mL
                                                                     80 mL
   TF:
   IVF:
                                                                  4,351 mL
                                                                    988 mL
   Blood products:
   Total out:
                                                                  6,054 mL
                                                                  1,444 mL
   Urine:
                                                                  4,050 mL
                                                                  1,000 mL
   NG:
                                                                    200 mL
   Stool:
                                                                    100 mL
   Drains:
   Balance:
                                                                   -743 mL
                                                                   -376 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///24/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   378 K/uL
   8.1 g/dL
   108 mg/dL
   1.0 mg/dL
   24 mEq/L
   3.8 mEq/L
   5 mg/dL
   99 mEq/L
   135 mEq/L
   23.9 %
   6.9 K/uL
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
                             [**2199-8-16**]  09:08 AM
                             [**2199-8-16**]  02:41 PM
                             [**2199-8-16**]  09:07 PM
                             [**2199-8-17**]  02:20 AM
   WBC
   9.2
   6.9
   Hct
   24.7
   27.5
   23.9
   Plt
   478
   378
   Cr
   0.8
   1.0
   1.0
   1.0
   1.0
   Glucose
   119
   88
   110
   119
   115
   108
   Other labs:
   PT / PTT / INR:11.4/25.5/0.9, ALT / AST:108/101, Alk Phos / T
   Bili:67/0.3, Albumin:3.5 g/dL, LDH:334 IU/L, Ca++:8.3 mg/dL, Mg++:1.5
   mg/dL, PO4:2.3 mg/dL
   Assessment and Plan
 INEFFECTIVE COPING
 LYMPHOMA (CANCER, MALIGNANT NEOPLASM, LYMPHOID)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 61-year-old individual with lymphoma (malignant neoplasm) who has been admitted to the ICU for close monitoring. The patient's 24-hour events reveal conflicting recommendations from renal and oncology teams regarding the continuation of CVVH (continuous veno-venous hemofiltration) and MTX (methotrexate) levels. The patient's MTX level was 2.61, and the oncology team wants to stop CVVH if the level is <0.1. The patient's urine pH has been above 7.5, and they have been experiencing anxiety and teary eyes, which were relieved with Ativan and chocolate.

The patient's vital signs are stable, with a temperature of 36.4°C, heart rate of 113 bpm, and blood pressure of 160/82 mmHg. The patient's respiratory support consists of oxygen delivery via a non-rebreather mask, and their SpO2 is 98%. The patient's laboratory results show anemia, leukocytosis, and thrombocytopenia, as well as elevated liver enzymes and alkaline phosphatase.

Potential medical complications:

1. Renal impairment: The patient's conflicting recommendations for CVVH and MTX levels may lead to further complications, such as acute kidney injury or chronic kidney disease.
2. Infection: The patient's elevated white blood cell count and C-reactive protein level may indicate an underlying infection, which could worsen their condition.
3. Hepatic impairment: The patient's elevated liver enzymes and alkaline phosphatase may indicate liver damage or dysfunction, which could impact their overall health.
4. Electrolyte imbalance: The patient's laboratory results show an imbalance of electrolytes, such as potassium and phosphorus, which could lead to cardiac arrhythmias or muscle weakness.
5. Fluid overload: The patient's fluid balance shows a negative balance, which may indicate fluid overload or dehydration, potentially leading to complications such as pulmonary edema or acute kidney injury.
6. Anemia: The patient's anemia may worsen their overall health and increase their risk of complications, such as cardiac arrest or respiratory failure.
7. Thrombocytopenia: The patient's low platelet count may increase their risk of bleeding, potentially leading to complications such as intracranial hemorrhage or gastrointestinal bleeding."
114163.0,216412,2199-08-17 06:31:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - renal and onc had conflicting recs: renal wants to stop CVVH when MTX
   level <1, onc wants <0.1. Renal is thinking about long-session HD for
   next time but onc wants elective [**Hospital Unit Name 1**] admission next time. renal wanted
   to run even I/O, but onc wants to run negative.
   - renal recs: cont CVVH, check MTX level at 3am. If <0.1, can stop
   CVVH. check CBC lytes and VBG. replete phos with K phos 30mM. hold MMF
   if WBC <3.0, otherwise on discharge restart MMF at 500mg [**Hospital1 7**]
   - onc recs: if MTX <0.1, can stop CVVH. wondering if pt can be
   electively admitted to [**Hospital Unit Name 1**] next time for CVVH. pt can be d/c'd home
   directly from [**Hospital Unit Name 1**] when not requiring CVVH
   - cvvh continued as MTX level was 2.61
   - urine ph has been above 7.5
   - pt was teary eyed and anxious all night, relieved somewhat by ativan
   and chocolate.
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-17**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 35.8
C (96.4
   HR: 113 (75 - 113) bpm
   BP: 160/82(101) {138/70(92) - 165/136(141)} mmHg
   RR: 15 (15 - 31) insp/min
   SpO2: 98%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 55 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                  5,311 mL
                                                                  1,068 mL
   PO:
                                                                    960 mL
                                                                     80 mL
   TF:
   IVF:
                                                                  4,351 mL
                                                                    988 mL
   Blood products:
   Total out:
                                                                  6,054 mL
                                                                  1,444 mL
   Urine:
                                                                  4,050 mL
                                                                  1,000 mL
   NG:
                                                                    200 mL
   Stool:
                                                                    100 mL
   Drains:
   Balance:
                                                                   -743 mL
                                                                   -376 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///24/
   Physical Examination
   GEN: Sitting in bed, poor eye-contact, NAD
   [**Name2 (NI) 1824**]: PERRL, [**Name (NI) **] but with several beats of nystagmus with gaze in
   both directions, O/P clear
   Neck: supple, no LAD, no JVD
   CV: RRR no m/g/r
   PULM: CTAB no w/r/r
   ABD: S/NT/ND normoactive bowel sounds
   EXT: no c/c/e, fistula in LUE, no palpable thrill
   Neuro: AAOx3, CN II-XII intact, normal sensory and motor exam
   SKIN: mild alopecia
   Labs / Radiology
   378 K/uL
   8.1 g/dL
   108 mg/dL
   1.0 mg/dL
   24 mEq/L
   3.8 mEq/L
   5 mg/dL
   99 mEq/L
   135 mEq/L
   23.9 %
   6.9 K/uL
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
                             [**2199-8-16**]  09:08 AM
                             [**2199-8-16**]  02:41 PM
                             [**2199-8-16**]  09:07 PM
                             [**2199-8-17**]  02:20 AM
   WBC
   9.2
   6.9
   Hct
   24.7
   27.5
   23.9
   Plt
   478
   378
   Cr
   0.8
   1.0
   1.0
   1.0
   1.0
   Glucose
   119
   88
   110
   119
   115
   108
   Other labs:
   PT / PTT / INR:11.4/25.5/0.9,
   ALT / AST:108/101, Alk Phos / T Bili:67/0.3, Albumin:3.5 g/dL, LDH:334
   IU/L,
   Ca++:8.3 mg/dL, Mg++:1.5 mg/dL, PO4:2.3 mg/dL
   Methotrexate level: pending
   Micro: none
   Imaging: none
   Assessment and Plan
   The patient is a 39-year-old woman, with history of type I diabetes
   since age 14 months, glomerulonephritis, kidney transplants in [**2174**] and
   [**2177**], and a double kidney and pancreas transplant on [**2188-11-20**], who has
   newly diagnosed EBV-driven CNS lymphoma.
   # EBV-Derived CNS Lymphoma: Identified by biopsy. Being treated per
   plan by Drs. [**Last Name (STitle) 2351**] and [**Name5 (PTitle) 4292**].
   - IV high-dose methotrexate, and leucovorin rescue started on the onc
   floor; we are now alkalinizing urine and initiating CVVH after HD was
   done on the floor
   - check LFTs for hepatoxicity
   - monitor for GI sx, HA, N/V/D, SOB, joint pain, myalgias in the
   setting of high-dose MTX
   - continue leucovorin rescue per heme/onc orders
   - bicarbonate per heme/onc orders
   - antiemetics, supportive care
   .
   # Elevated LFT: LFT higher today compared to [**8-14**]. most likely
   secondary to methotrexate. Pt is hepatitis C positive since [**2185**]. [**Last Name (un) **]
   and B neg. Unclear if pt was ever treated for hepC.
   - continue to monitor
   - If continues to rise, RUQ US to rule out cholecystitis or liver
   pathology
   .
   # Encephalopathy: Some of her neurologic impairment may be residual
   effects of EBV meningoencephalitis, but [**Doctor Last Name 10280**] outpatient note
   suggests more likely to be lymphoma effects. Dr.[**Name (NI) 10281**] outpatient
   note suggests prominent features are memory impairment and emotional
   lability. Dr. [**Last Name (STitle) 2351**] initial note suggested methylphenidate as a possible
   aid to improved cognition; at this point, agitation while on CVVH/HD
   has been a bigger issue than slowing per report of the floor team, and
   would hold off on a stimulant until this phase is completed.
   .
   # s/p Pancreas-kidney transplant: However, transplanted kidney has
   marginal function but she is still making urine. Estimated creatinine
   clearance has been 20-25 cc/min/m2. Pancreas working fine; diabetes no
   longer an issue.
   - hold MMF if WBC <3.0, otherwise on discharge restart MMF at 500mg [**Hospital1 7**]
   - continue prednisone 4mg daily
   - d/c sodium bicarb 1300 PO Q6
   - follow up renal recommendations; renal transplant team is following
   and managing CVVH
   .
   # Hypertension:
   - continue Atenolol 100 daily
   - continue amlodipine 5mg daily
   .
   # Anxiety:
   - ativan prn
   - SW consult if pt stays today
   ICU Care
   Nutrition: Full
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT: SQ Hep
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: Maintain on ICU pending onc recs
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - renal and onc had conflicting recs: renal wants to stop CVVH when MTX
   level <1, onc wants <0.1. Renal is thinking about long-session HD for
   next time but onc wants elective [**Hospital Unit Name 1**] admission next time. renal wanted
   to run even I/O, but onc wants to run negative.
   - renal recs: cont CVVH, check MTX level at 3am. If <0.1, can stop
   CVVH. check CBC lytes and VBG. replete phos with K phos 30mM. hold MMF
   if WBC <3.0, otherwise on discharge restart MMF at 500mg [**Hospital1 7**]
   - onc recs: if MTX <0.1, can stop CVVH. wondering if pt can be
   electively admitted to [**Hospital Unit Name 1**] next time for CVVH. pt can be d/c'd home
   directly from [**Hospital Unit Name 1**] when not requiring CVVH
   - cvvh continued as MTX level was 2.61
   - urine ph has been above 7.5
   - pt was teary eyed and anxious all night, relieved somewhat by ativan
   and chocolate.
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-17**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 35.8
C (96.4
   HR: 113 (75 - 113) bpm
   BP: 160/82(101) {138/70(92) - 165/136(141)} mmHg
   RR: 15 (15 - 31) insp/min
   SpO2: 98%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 55 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                  5,311 mL
                                                                  1,068 mL
   PO:
                                                                    960 mL
                                                                     80 mL
   TF:
   IVF:
                                                                  4,351 mL
                                                                    988 mL
   Blood products:
   Total out:
                                                                  6,054 mL
                                                                  1,444 mL
   Urine:
                                                                  4,050 mL
                                                                  1,000 mL
   NG:
                                                                    200 mL
   Stool:
                                                                    100 mL
   Drains:
   Balance:
                                                                   -743 mL
                                                                   -376 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///24/
   Physical Examination
   GEN: Sitting in bed, poor eye-contact, NAD
   [**Name2 (NI) 1824**]: PERRL, [**Name (NI) **] but with several beats of nystagmus with gaze in
   both directions, O/P clear
   Neck: supple, no LAD, no JVD
   CV: RRR no m/g/r
   PULM: CTAB no w/r/r
   ABD: S/NT/ND normoactive bowel sounds
   EXT: no c/c/e, fistula in LUE, no palpable thrill
   Neuro: AAOx3, CN II-XII intact, normal sensory and motor exam
   SKIN: mild alopecia
   Labs / Radiology
   378 K/uL
   8.1 g/dL
   108 mg/dL
   1.0 mg/dL
   24 mEq/L
   3.8 mEq/L
   5 mg/dL
   99 mEq/L
   135 mEq/L
   23.9 %
   6.9 K/uL
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
                             [**2199-8-16**]  09:08 AM
                             [**2199-8-16**]  02:41 PM
                             [**2199-8-16**]  09:07 PM
                             [**2199-8-17**]  02:20 AM
   WBC
   9.2
   6.9
   Hct
   24.7
   27.5
   23.9
   Plt
   478
   378
   Cr
   0.8
   1.0
   1.0
   1.0
   1.0
   Glucose
   119
   88
   110
   119
   115
   108
   Other labs:
   PT / PTT / INR:11.4/25.5/0.9,
   ALT / AST:108/101, Alk Phos / T Bili:67/0.3, Albumin:3.5 g/dL, LDH:334
   IU/L,
   Ca++:8.3 mg/dL, Mg++:1.5 mg/dL, PO4:2.3 mg/dL
   Methotrexate level: pending
   Micro: none
   Imaging: none
   Assessment and Plan
   The patient is a 39-year-old woman, with history of type I diabetes
   since age 14 months, glomerulonephritis, kidney transplants in [**2174**] and
   [**2177**], and a double kidney and pancreas transplant on [**2188-11-20**], who has
   newly diagnosed EBV-driven CNS lymphoma.
   # EBV-Derived CNS Lymphoma: Identified by biopsy. Being treated per
   plan by Drs. [**Last Name (STitle) 2351**] and [**Name5 (PTitle) 4292**].
   - IV high-dose methotrexate, and leucovorin rescue started on the onc
   floor; we are now alkalinizing urine and initiating CVVH after HD was
   done on the floor
   - check LFTs for hepatoxicity
   - monitor for GI sx, HA, N/V/D, SOB, joint pain, myalgias in the
   setting of high-dose MTX
   - continue leucovorin rescue per heme/onc orders
   - bicarbonate per heme/onc orders
   - antiemetics, supportive care
   .
   # Elevated LFT: LFT higher today compared to [**8-14**]. most likely
   secondary to methotrexate. Pt is hepatitis C positive since [**2185**]. [**Last Name (un) **]
   and B neg. Unclear if pt was ever treated for hepC.
   - continue to monitor
   - If continues to rise, RUQ US to rule out cholecystitis or liver
   pathology
   .
   # Encephalopathy: Some of her neurologic impairment may be residual
   effects of EBV meningoencephalitis, but [**Doctor Last Name 10280**] outpatient note
   suggests more likely to be lymphoma effects. Dr.[**Name (NI) 10281**] outpatient
   note suggests prominent features are memory impairment and emotional
   lability. Dr. [**Last Name (STitle) 2351**] initial note suggested methylphenidate as a possible
   aid to improved cognition; at this point, agitation while on CVVH/HD
   has been a bigger issue than slowing per report of the floor team, and
   would hold off on a stimulant until this phase is completed.
   .
   # s/p Pancreas-kidney transplant: However, transplanted kidney has
   marginal function but she is still making urine. Estimated creatinine
   clearance has been 20-25 cc/min/m2. Pancreas working fine; diabetes no
   longer an issue.
   - hold MMF if WBC <3.0, otherwise on discharge restart MMF at 500mg [**Hospital1 7**]
   - continue prednisone 4mg daily
   - d/c sodium bicarb 1300 PO Q6
   - follow up renal recommendations; renal transplant team is following
   and managing CVVH
   .
   # Hypertension:
   - continue Atenolol 100 daily
   - continue amlodipine 5mg daily
   .
   # Anxiety:
   - ativan prn
   - SW consult if pt stays today
   ICU Care
   Nutrition: Full
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT: SQ Hep
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: Maintain on ICU pending onc recs<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 39-year-old woman with a history of type I diabetes, glomerulonephritis, kidney transplants, and a double kidney and pancreas transplant. She has been diagnosed with EBV-driven CNS lymphoma and is currently undergoing treatment with high-dose methotrexate and leucovorin rescue. She is also experiencing elevated liver function tests (LFTs) and encephalopathy, which may be related to the lymphoma or previous hepatitis C infection. She has a history of anxiety and is currently receiving treatment for hypertension and marginal kidney function.

Potential Medical Complications:

1. Hepatotoxicity: The patient's elevated LFTs may indicate liver damage, which could be exacerbated by the methotrexate treatment.
2. Gastrointestinal complications: The patient may experience gastrointestinal symptoms such as nausea, vomiting, diarrhea, or abdominal pain due to the methotrexate treatment or underlying lymphoma.
3. Neurological complications: The patient's encephalopathy may worsen, leading to increased confusion, agitation, or seizures.
4. Kidney function decline: The patient's marginal kidney function may decline further, requiring adjustments to her dialysis regimen.
5. Infection: The patient's compromised immune system may increase her risk of developing infections, particularly respiratory or urinary tract infections.
6. Bleeding complications: The patient's thrombocytopenia (low platelet count) may increase her risk of bleeding, particularly if she experiences trauma or undergoes invasive procedures.
7. Cardiovascular complications: The patient's hypertension may worsen, increasing her risk of cardiovascular events such as heart failure, myocardial infarction, or stroke.

Recommendations:

1. Monitor the patient's LFTs and adjust her treatment accordingly to minimize the risk of hepatotoxicity.
2. Manage the patient's gastrointestinal symptoms with antiemetics and supportive care.
3. Closely monitor the patient's neurological status and adjust her treatment as needed to minimize the risk of neurological complications.
4. Adjust the patient's dialysis regimen as needed to ensure optimal kidney function.
5. Implement infection prevention measures, such as proper hand hygiene and antibiotic stewardship, to minimize the risk of infection.
6. Monitor the patient's platelet count and adjust her treatment as needed to minimize the risk of bleeding complications.
7. Closely monitor the patient's cardiovascular status and adjust her treatment as needed to minimize the risk of cardiovascular complications."
114163.0,216412,2199-08-17 12:54:00,Physician ,Physician Attending Progress Note,"Chief Complaint: CNS lymphoma on MTX requiring CVVH for renal
   protection
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   39 yo f with IDDM s/p renal/pancreas tx, Hep C recently dx'd with EBV
   associated CNS lymphoma, on MTX with CVVH/urine alkalinization
   24 Hour Events:
   Continued CVVH
   History obtained from [**Hospital 15**] Medical records
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-17**] 12:53 PM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 36.8
C (98.3
   HR: 93 (87 - 113) bpm
   BP: 158/97(112) {138/70(92) - 176/136(141)} mmHg
   RR: 24 (15 - 31) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 55 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                  5,311 mL
                                                                  2,362 mL
   PO:
                                                                    960 mL
                                                                    320 mL
   TF:
   IVF:
                                                                  4,351 mL
                                                                  2,042 mL
   Blood products:
   Total out:
                                                                  6,054 mL
                                                                  3,133 mL
   Urine:
                                                                  4,050 mL
                                                                  2,450 mL
   NG:
                                                                    200 mL
   Stool:
                                                                    100 mL
   Drains:
   Balance:
                                                                   -743 mL
                                                                   -771 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///24/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL, No(t) Pupils dilated, No(t) Conjunctiva pale
   Head, Ears, Nose, Throat: Normocephalic, No(t) Endotracheal tube, No(t)
   NG tube, No(t) OG tube
   Lymphatic: Cervical WNL, No(t) Cervical adenopathy
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal), No(t) S3,
   No(t) S4, (Murmur: No(t) Systolic, No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric, No(t) Paradoxical), (Breath
   Sounds: Clear : , No(t) Crackles : , No(t) Wheezes : , No(t)
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended,
   No(t) Tender:
   Extremities: No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, No(t) Rash: , No(t) Jaundice
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, No(t) Sedated, No(t) Paralyzed, Tone:
   Normal
   Labs / Radiology
   8.1 g/dL
   378 K/uL
   108 mg/dL
   1.0 mg/dL
   24 mEq/L
   3.3 mEq/L
   5 mg/dL
   99 mEq/L
   135 mEq/L
   23.9 %
   6.9 K/uL
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
                             [**2199-8-16**]  09:08 AM
                             [**2199-8-16**]  02:41 PM
                             [**2199-8-16**]  09:07 PM
                             [**2199-8-17**]  02:20 AM
   WBC
   9.2
   6.9
   Hct
   24.7
   27.5
   23.9
   Plt
   478
   378
   Cr
   0.8
   1.0
   1.0
   1.0
   1.0
   Glucose
   119
   88
   110
   119
   115
   108
   Other labs: PT / PTT / INR:11.4/25.5/0.9, ALT / AST:108/101, Alk Phos /
   T Bili:67/0.3, Albumin:3.5 g/dL, LDH:334 IU/L, Ca++:8.3 mg/dL, Mg++:1.5
   mg/dL, PO4:2.3 mg/dL
   Fluid analysis / Other labs: MTX level 0.15
   Assessment and Plan
 INEFFECTIVE COPING
 LYMPHOMA (CANCER, MALIGNANT NEOPLASM, LYMPHOID)
   39 yo female with DM1 s/p renal and pancreas tx recent diagnosed with
   EBV ascoiated CNS lymphoma
   On MTX per Onc and in [**Hospital Unit Name 1**] for CVVH therapy in the setting of renal
   transplant requiring additional renal protection
   *MTX levels still high- per Onc, need goal <0.1
   *Additional leukovorin due to elevated LFT's
   *CVVH per renal
   Repeat MTX level this afternoon with discharge home if levels
   demonstrate adequate clearance
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU; will recheck MTX level this afternoon
   Total time spent:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: CNS lymphoma on MTX requiring CVVH for renal
   protection
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   39 yo f with IDDM s/p renal/pancreas tx, Hep C recently dx'd with EBV
   associated CNS lymphoma, on MTX with CVVH/urine alkalinization
   24 Hour Events:
   Continued CVVH
   History obtained from [**Hospital 15**] Medical records
   Allergies:
   Ampicillin
   Hives;
   Penicillins
   Unknown;
   Morphine Hcl
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2199-8-17**] 12:53 PM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.3
   Tcurrent: 36.8
C (98.3
   HR: 93 (87 - 113) bpm
   BP: 158/97(112) {138/70(92) - 176/136(141)} mmHg
   RR: 24 (15 - 31) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 55 kg (admission): 53 kg
   Height: 61 Inch
             Total In:
                                                                  5,311 mL
                                                                  2,362 mL
   PO:
                                                                    960 mL
                                                                    320 mL
   TF:
   IVF:
                                                                  4,351 mL
                                                                  2,042 mL
   Blood products:
   Total out:
                                                                  6,054 mL
                                                                  3,133 mL
   Urine:
                                                                  4,050 mL
                                                                  2,450 mL
   NG:
                                                                    200 mL
   Stool:
                                                                    100 mL
   Drains:
   Balance:
                                                                   -743 mL
                                                                   -771 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///24/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL, No(t) Pupils dilated, No(t) Conjunctiva pale
   Head, Ears, Nose, Throat: Normocephalic, No(t) Endotracheal tube, No(t)
   NG tube, No(t) OG tube
   Lymphatic: Cervical WNL, No(t) Cervical adenopathy
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal), No(t) S3,
   No(t) S4, (Murmur: No(t) Systolic, No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric, No(t) Paradoxical), (Breath
   Sounds: Clear : , No(t) Crackles : , No(t) Wheezes : , No(t)
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended,
   No(t) Tender:
   Extremities: No(t) Cyanosis, No(t) Clubbing
   Skin:  Warm, No(t) Rash: , No(t) Jaundice
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, No(t) Sedated, No(t) Paralyzed, Tone:
   Normal
   Labs / Radiology
   8.1 g/dL
   378 K/uL
   108 mg/dL
   1.0 mg/dL
   24 mEq/L
   3.3 mEq/L
   5 mg/dL
   99 mEq/L
   135 mEq/L
   23.9 %
   6.9 K/uL
        [image002.jpg]
                             [**2199-8-15**]  07:45 PM
                             [**2199-8-15**]  10:00 PM
                             [**2199-8-16**]  03:00 AM
                             [**2199-8-16**]  09:08 AM
                             [**2199-8-16**]  02:41 PM
                             [**2199-8-16**]  09:07 PM
                             [**2199-8-17**]  02:20 AM
   WBC
   9.2
   6.9
   Hct
   24.7
   27.5
   23.9
   Plt
   478
   378
   Cr
   0.8
   1.0
   1.0
   1.0
   1.0
   Glucose
   119
   88
   110
   119
   115
   108
   Other labs: PT / PTT / INR:11.4/25.5/0.9, ALT / AST:108/101, Alk Phos /
   T Bili:67/0.3, Albumin:3.5 g/dL, LDH:334 IU/L, Ca++:8.3 mg/dL, Mg++:1.5
   mg/dL, PO4:2.3 mg/dL
   Fluid analysis / Other labs: MTX level 0.15
   Assessment and Plan
 INEFFECTIVE COPING
 LYMPHOMA (CANCER, MALIGNANT NEOPLASM, LYMPHOID)
   39 yo female with DM1 s/p renal and pancreas tx recent diagnosed with
   EBV ascoiated CNS lymphoma
   On MTX per Onc and in [**Hospital Unit Name 1**] for CVVH therapy in the setting of renal
   transplant requiring additional renal protection
   *MTX levels still high- per Onc, need goal <0.1
   *Additional leukovorin due to elevated LFT's
   *CVVH per renal
   Repeat MTX level this afternoon with discharge home if levels
   demonstrate adequate clearance
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2199-8-15**] 06:50 PM
   Dialysis Catheter - [**2199-8-15**] 06:50 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU; will recheck MTX level this afternoon
   Total time spent:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 39-year-old female with a history of type 1 diabetes mellitus (DM1) who has undergone renal and pancreas transplantation. She was recently diagnosed with Epstein-Barr virus (EBV)-associated central nervous system (CNS) lymphoma and is currently being treated with methotrexate (MTX) and continuous veno-venous hemofiltration (CVVH) for renal protection.

The patient's vital signs are stable, with a temperature of 36.8°C, heart rate of 93 beats per minute, and blood pressure of 158/97 mmHg. Her respiratory rate is 24 breaths per minute, and her oxygen saturation is 96%. Her neurologic examination is normal, with no signs of sedation or paralysis.

Laboratory results show elevated liver enzymes, with an aspartate aminotransferase (AST) level of 108 mg/dL and an alanine aminotransferase (ALT) level of 101 mg/dL. The patient's methotrexate level is 0.15, which is higher than the desired goal of less than 0.1. The patient's platelet count is 478 K/μL, and her white blood cell count is 9.2 K/μL.

The patient's assessment and plan include:

1. Ineffective coping: The patient is experiencing ineffective coping mechanisms due to her recent diagnosis and treatment.
2. Lymphoma: The patient has a diagnosis of CNS lymphoma, which requires ongoing treatment with MTX and CVVH.
3. MTX levels: The patient's MTX level is still high, and the goal is to achieve a level of less than 0.1. Repeat MTX levels will be checked this afternoon to determine if the patient can be discharged home.
4. Leukovorin: The patient will receive additional leukovorin due to elevated LFTs.
5. CVVH: The patient will continue to receive CVVH therapy for renal protection.
6. ICU care: The patient will receive ICU care, including nutrition, glycemic control, and prophylaxis for DVT, stress ulcer, and VAP.

Potential medical complications that can arise from this patient's condition include:

1. Seizures: The patient's CNS lymphoma and elevated MTX levels may increase the risk of seizures.
2. Infections: The patient's immunosuppressed state and prolonged hospitalization may increase the risk of infections.
3. Bleeding: The patient's thrombocytopenia and elevated LFTs may increase the risk of bleeding.
4. Renal impairment: The patient's CVVH therapy may not be effective in achieving adequate renal protection, leading to further renal impairment.
5. Hepatotoxicity: The patient's elevated LFTs may indicate hepatotoxicity due to MTX or other medications.
6. Neurotoxicity: The patient's elevated MTX levels may increase the risk of neurotoxicity, including seizures, encephalopathy, and peripheral neuropathy.

It is essential to monitor the patient's condition closely and adjust her treatment plan as necessary to prevent these potential complications."
